JP2016147858A5 - - Google Patents

Download PDF

Info

Publication number
JP2016147858A5
JP2016147858A5 JP2016023658A JP2016023658A JP2016147858A5 JP 2016147858 A5 JP2016147858 A5 JP 2016147858A5 JP 2016023658 A JP2016023658 A JP 2016023658A JP 2016023658 A JP2016023658 A JP 2016023658A JP 2016147858 A5 JP2016147858 A5 JP 2016147858A5
Authority
JP
Japan
Prior art keywords
dipiperidinyl
mycaminosyl
tylonolide
composition
crystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016023658A
Other languages
English (en)
Japanese (ja)
Other versions
JP6343624B2 (ja
JP2016147858A (ja
Filing date
Publication date
Priority claimed from EP07113244A external-priority patent/EP2019112A1/en
Application filed filed Critical
Publication of JP2016147858A publication Critical patent/JP2016147858A/ja
Publication of JP2016147858A5 publication Critical patent/JP2016147858A5/ja
Application granted granted Critical
Publication of JP6343624B2 publication Critical patent/JP6343624B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016023658A 2007-07-26 2016-02-10 マクロライド固体状形態 Active JP6343624B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113244A EP2019112A1 (en) 2007-07-26 2007-07-26 Macrolide solid-state forms
EP07113244.3 2007-07-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013251788A Division JP2014088394A (ja) 2007-07-26 2013-12-05 マクロライド固体状形態

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2018021676A Division JP2018104449A (ja) 2007-07-26 2018-02-09 マクロライド固体状形態
JP2018021677A Division JP2018109020A (ja) 2007-07-26 2018-02-09 マクロライド固体状形態

Publications (3)

Publication Number Publication Date
JP2016147858A JP2016147858A (ja) 2016-08-18
JP2016147858A5 true JP2016147858A5 (cg-RX-API-DMAC7.html) 2016-09-29
JP6343624B2 JP6343624B2 (ja) 2018-06-13

Family

ID=39467287

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2010517412A Active JP5925989B2 (ja) 2007-07-26 2008-07-25 マクロライド固体状形態
JP2013251788A Pending JP2014088394A (ja) 2007-07-26 2013-12-05 マクロライド固体状形態
JP2016023658A Active JP6343624B2 (ja) 2007-07-26 2016-02-10 マクロライド固体状形態
JP2018021677A Pending JP2018109020A (ja) 2007-07-26 2018-02-09 マクロライド固体状形態
JP2018021676A Pending JP2018104449A (ja) 2007-07-26 2018-02-09 マクロライド固体状形態
JP2020114648A Pending JP2020172516A (ja) 2007-07-26 2020-07-02 マクロライド固体状形態
JP2020114652A Pending JP2020172517A (ja) 2007-07-26 2020-07-02 マクロライド固体状形態

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2010517412A Active JP5925989B2 (ja) 2007-07-26 2008-07-25 マクロライド固体状形態
JP2013251788A Pending JP2014088394A (ja) 2007-07-26 2013-12-05 マクロライド固体状形態

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018021677A Pending JP2018109020A (ja) 2007-07-26 2018-02-09 マクロライド固体状形態
JP2018021676A Pending JP2018104449A (ja) 2007-07-26 2018-02-09 マクロライド固体状形態
JP2020114648A Pending JP2020172516A (ja) 2007-07-26 2020-07-02 マクロライド固体状形態
JP2020114652A Pending JP2020172517A (ja) 2007-07-26 2020-07-02 マクロライド固体状形態

Country Status (13)

Country Link
EP (3) EP2019112A1 (cg-RX-API-DMAC7.html)
JP (7) JP5925989B2 (cg-RX-API-DMAC7.html)
KR (2) KR102508115B1 (cg-RX-API-DMAC7.html)
CN (5) CN101778858B (cg-RX-API-DMAC7.html)
AU (1) AU2008278969B8 (cg-RX-API-DMAC7.html)
BR (1) BRPI0814318B1 (cg-RX-API-DMAC7.html)
CA (1) CA2693801C (cg-RX-API-DMAC7.html)
ES (2) ES2805534T3 (cg-RX-API-DMAC7.html)
HU (1) HUE031449T2 (cg-RX-API-DMAC7.html)
RU (1) RU2476438C2 (cg-RX-API-DMAC7.html)
TW (1) TWI427083B (cg-RX-API-DMAC7.html)
WO (1) WO2009013351A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201000188B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2089408T3 (pl) 2006-07-28 2012-03-30 Intervet Int Bv Sposób syntezy makrolidu
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
AU2012342548B2 (en) 2011-11-25 2017-08-24 Elanco Animal Health Gmbh Antibacterial tylosin derivatives and methods for their preparation
CN102816196A (zh) * 2012-09-10 2012-12-12 河北远征药业有限公司 泰地罗新半抗原、人工抗原及其制备方法
PE20160207A1 (es) * 2013-05-23 2016-05-22 Kitasato Inst Derivados de tilosina y metodo para su preparacion
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20,23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20,23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104774223A (zh) * 2015-03-26 2015-07-15 宁夏泰瑞制药股份有限公司 一种利用泰乐菌素碱生产泰地罗新的方法
CN105254693B (zh) * 2015-11-13 2017-12-22 周金华 一种泰地罗新的合成方法
CN106046084B (zh) * 2016-06-02 2019-08-09 天津大学 泰地罗新丙酮溶剂化合物及制备方法
CN106008629B (zh) * 2016-06-02 2019-11-22 天津大学 泰地罗新1,4-二氧六环溶剂化合物及制备方法
CN106083958B (zh) * 2016-06-02 2019-07-23 天津大学 泰地罗新环己烷溶剂化合物及制备方法
CN109721633A (zh) * 2017-10-31 2019-05-07 齐鲁晟华制药有限公司 一种泰地罗新晶型a及其制备方法
KR20210052389A (ko) 2018-08-27 2021-05-10 리제너론 파마슈티칼스 인코포레이티드 다운스트림 정제에서의 라만 분광법의 사용
CN111349130A (zh) * 2018-12-21 2020-06-30 齐鲁动物保健品有限公司 一种泰地罗新晶型b及其制备方法
JP2023551551A (ja) 2020-12-03 2023-12-08 インターベット インターナショナル ベー. フェー. 腐蹄症の治療方法
CN114213484A (zh) * 2021-12-21 2022-03-22 河北远征药业有限公司 一种泰地罗新1,2-丙二醇溶剂化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761588A (en) * 1969-02-06 1973-09-25 Meiji Seika Kaisha Antibiotics and production thereof
US4820695A (en) 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
AU561147B2 (en) 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
YU43658B (en) * 1983-07-18 1989-10-31 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladinosyl-12,0-desosaminyl-4,5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)hexadeca-1(2)-ene-8
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4920103A (en) 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
DE60008895T2 (de) * 1999-08-30 2005-01-20 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Makrolid-antibiotika und behandlung von pasteurellosis
WO2004080391A2 (en) * 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2005019226A1 (en) * 2003-08-26 2005-03-03 Biocon Limited A process for the recovery of substantially pure tricyclic macrolide
EP1833835A1 (en) * 2005-01-05 2007-09-19 Teva Gyogyszergyar Zartkoruen Müködö R Szv Nytarsa Amorphous tacrolimus and preparation thereof
CN101506220B (zh) * 2006-07-28 2012-10-17 英特威国际有限公司 大环内酯合成方法
PL2089408T3 (pl) * 2006-07-28 2012-03-30 Intervet Int Bv Sposób syntezy makrolidu
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms

Similar Documents

Publication Publication Date Title
JP2016147858A5 (cg-RX-API-DMAC7.html)
JP2019532928A5 (cg-RX-API-DMAC7.html)
JP2018507914A5 (cg-RX-API-DMAC7.html)
RU2010107057A (ru) Твердые формы макролидов
JP2017507181A5 (cg-RX-API-DMAC7.html)
JP2016512425A5 (cg-RX-API-DMAC7.html)
UA104997C2 (uk) Аміди азотвмісних насичених гетероциклів та 3,5-діаміно-6-хлор-2-піразинкарбонової кислоти як лікарський засіб
JP2015509075A5 (cg-RX-API-DMAC7.html)
JP2012092341A5 (cg-RX-API-DMAC7.html)
JP2018534348A5 (cg-RX-API-DMAC7.html)
JP2013519675A5 (cg-RX-API-DMAC7.html)
JP2016511753A5 (cg-RX-API-DMAC7.html)
JP2016503052A5 (cg-RX-API-DMAC7.html)
JP2014515351A5 (cg-RX-API-DMAC7.html)
JP2017505785A5 (cg-RX-API-DMAC7.html)
JP2015510916A5 (cg-RX-API-DMAC7.html)
JP2012506872A5 (cg-RX-API-DMAC7.html)
CN113825754A (zh) 包括甲基和三氟甲基的双取代磺酰胺类选择性bcl-2抑制剂
JP2016529306A5 (cg-RX-API-DMAC7.html)
JP2011527333A5 (cg-RX-API-DMAC7.html)
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
JP2015051983A5 (cg-RX-API-DMAC7.html)
JP2019516739A5 (cg-RX-API-DMAC7.html)
JP2020514270A5 (cg-RX-API-DMAC7.html)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法